Astec LifeSciences Limited — Board Meeting, 30-01-2026: Outcome of Board Meeting
30-01-2026 | 05:49 pm
30-01-2026 | 05:49 pm
Astec LifeSciences announced its board meeting decisions: approved the financial results for the quarter and nine-month period. Consolidated Q3 revenue hit ₹124.72 Cr, with a loss of ₹15.69 Cr. Mugdha Khare resigned as CFO, effective March 6, 2026, with Deepak Ochani taking over from April 1, 2026.
No comments yet. Be the first to comment!
